C69
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosis of uveamelanoma; prior to first-line oncologic therapy, radiotherapy (cyberknife) or enucleation; curative medical treatment approach or life expectancy at least 6 months; good German language skills; written informed consent.
Exclusion criteria
Exclusion criteria: - Failure to meet inclusion criteria - Shortened life expectancy of less than 6 months - All general diseases that do not allow sports activity in particular: o Clinical-manifest heart failure (NYHA III-IV). o Respiratory partial or global insufficiency o Permanent thrombocytopenia <10,000/µl, e.g., refractory autoimmune thrombocytopenia o Congenital or acquired thrombocytopathies or coagulation disorders. o Symptomatic CHD (clearance certificate required, stress ECG and cardiac ultrasound recommended if necessary) o Severe refractory hypertension o Uncontrollable COPD o Uncontrolled cerebral seizure disorder o Severe anemia (requiring transfusion). - Medical or mental condition that, in the opinion of the investigator, does not allow the patient to participate in the study or provide a legally binding signature on the informed consent form - Lack of willingness to store and share personal medical records as part of the protocol - Participation in another exercise therapy study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Health-related quality of life | — |
Secondary
| Measure | Time frame |
|---|---|
| - Hand-eye coordination - Endurance capacity - Static and dynamic balance - Movement behavior/physical activity - Psychological well-being (anxiety and depression) - Neck pain - Employment and financial status | — |
Countries
Germany
Contacts
Universitätsklinikum Köln